Abstract PR13: Inhibition of RNA polymerase I transcription activates targeted DNA damage response and enhances the efficacy of PARP inhibitors in high-grade serous ovarian cancer
Sanij, Elaine, Hannan, Katherine, Xuan, Jiachen, Yan, Shunfei, Ahern, Jessica A., Trigos, Anna S., Brajanovski, Natalie, Son, Jinbae, Chan, Keefe T., Kondrashova, Olga, Lieschke, Elizabeth, Wakefield, Matthew J., Ellis, Sarah, Cullinane, Carleen, Poortinga, Gretchen, Khanna, Kum Kum, Mileshkin, Linda, McArthur, Grant A., Soong, John, Berns, Els M., Hannan, Ross D., Scott, Clare L., Sheppard, Karen E., Pearson, Richard B.
Published in Clinical cancer research (01.07.2020)
Published in Clinical cancer research (01.07.2020)
Get full text
Journal Article